Pleopharma To Present New Data on Cannabis Withdrawal in Patients With …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyTHCAnxietyDosingNeurology Why This Matters Clinicians treating cannabis use disorder need…
Leafwell Publishes New PTSD Study, Builds on Evidence Supporting Medical Cannabis for …
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchPainSafetyPolicyAnxietyNeurology Clinical Summary # Clinical Summary This study contributes to…
Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry …
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyResearchMental HealthNeurologyTHCPediatrics Clinical Summary A Harvard neuroscientist has submitted…
Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 …
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPolicyMental HealthSafetyNeurologyAnxietyAging Why This Matters This correction to Global Burden of Disease data…
Cannabis Use Linked to GERD Risks
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyMental HealthTHCAnxietyNeurologyDosing Why This Matters Clinicians should counsel patients with GERD or at…
Prospects for neuroprotective therapies in glaucoma: drug targets an
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchNeurologySafetyCBDTHCAnxietyAging Why This Matters Cannabinoid signaling, particularly through anandamide…
Kentucky Ends Out-of-State Medical Marijuana Importation
Kentucky medical marijuana program ends the practice of patients bringing cannabis from out of state. This shift improves access to regulated, tested products for patients. Clinicians should understand these changes to guide patient care effectively.
Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry …
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyPolicyResearchMental HealthSafetyPediatricsTHC Why This Matters Clinicians need to understand this evidence…
Swiss canton St. Gallen launches new large-scale cannabis study – SWI swissinfo.ch
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchHempSafetyMental HealthAnxietyNeurology Why This Matters Swiss large-scale cannabis studies provide…
Bouts of vomiting, nausea and abdominal pain: The little-known syndrome stalking daily …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCMental HealthNeurologyDosingPain Why This Matters Cannabinoid hyperemesis syndrome (CHS) is an…
